aml risk stratification: cytogenetics and mutational analysis - part 1
Published 4 years ago • 785 plays • Length 8:46Download video MP4
Download video MP3
Similar videos
-
12:16
aml risk stratification: cytogenetics and mutational analysis - part 2
-
3:47
the impact of cytogenetic-risk stratification on aml outcomes
-
2:57
know aml | risk stratification
-
2:03
aml risk stratification
-
15:26
classsification & risk stratification of aml hwei fang tien
-
1:52
aml: the cytogenetic risk score
-
2:31
updates in the diagnosis, risk stratification & treatment of aml: who, icc, and eln classifications
-
2:43
diagnostic tools for aml
-
5:18
risk stratification of myelodysplastic syndromes and acute myeloid leukemia
-
52:20
acute myeloid leukemia: incorporating novel treatment approaches into clinical pathways
-
1:25
the impact of cytogenetics and molecular genetics on outcomes in aml
-
1:41
the importance of integrating genomic and cytogenetic data in treatment decisions for aml
-
9:58
the biology of secondary aml and therapy-related aml - part 2
-
4:25
recent developments in the mutational landscape and molecular basis of aml
-
11:04
the hematopathologist’s role in the diagnosis of acute myeloid leukemia - part 1
-
1:13:10
webinar: aml risk stratification - understanding fragment analysis and ngs panel test results
-
1:30:24
the oncology nurse takes on aml
-
2:13
high-risk aml: the 2022 eln risk classification and challenges in this patient population